2,003
Views
6
CrossRef citations to date
0
Altmetric
Pain Medicine

Insight into chronic pain in the United States: descriptive results from the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) validation study

, , , , , , , , , & show all
Pages 483-492 | Received 27 May 2020, Accepted 02 Nov 2020, Published online: 18 Jan 2021

References

  • Institute of Medicine (IOM). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press; 2011.
  • Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769–780.
  • Medicine I. O. Pain as a public health challenge. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press; 2011.
  • Rosenblum A, Marsch LA, Joseph H, et al. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008;16(5):405–416.
  • Vowles KE, McEntee ML, Julnes PS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–576.
  • Raffaeli W, Arnaudo E. Pain as a disease: an overview. J Pain Res. 2017;10:2003–2008.
  • Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician. 2017;20(2S):S93–S109.
  • Burcher KM, Suprun A, Smith A. Risk factors for opioid use disorders in adult postsurgical patients. Cureus. 2018;10(5):e2611.
  • Health and Human Services. HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis 2017. Available from: https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html
  • Food and Drug Administration. Labeling Supplement and PMR required 2013. [cited 2018 October 4]. Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf
  • Food and Drug Administration. New PMR required 2016. [cited 2018 October 4]. Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM484415.pdf
  • Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7(9):671–681.
  • Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130(1–2):144–156.
  • Butler SF, Fernandez K, Benoit C, et al. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9(4):360–372.
  • Coambs R, Jarry J, Santhiapillai A, et al. The SISAP: a new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within general medical practice. Pain Res Manage. 1996;1(3):155–162.
  • Setnik B, Roland CL, Barsdorf AI, et al. The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain. Curr Med Res Opin. 2017;33(6):1067–1076.
  • Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–442.
  • Coyne KS, Barsdorf AI, Brooks A, et al. Establishing the content validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) among chronic pain patients. CMRO. 2020. DOI:10.1080/03007995.2020.1865891
  • Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–2296.
  • Dorrance KA, Ramchandani S, Neil N, et al. Leveraging the military health system as a laboratory for health care reform. Mil Med. 2013;178(2):142–145.
  • Maruish M. User’s manual for the SF-36v2 health survey. Lincoln, RI: QualityMetric Incorporated; 1993.
  • McHorney CA, Ware JE Jr, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40–66.
  • McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247–263.
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
  • Ware JE. Jr. SF-36 Health Survey update. The use of psychological testing for treatment planning and outcome assessment, Vol. 3. Mahwah, NJ: Lawrence Erlbaum Associates; 2004. p. 693–718.
  • Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129–138.
  • Cleeland C. Assessment in cancer. In: Osoba D, editor. Effect of cancer on quality of life. Boca Raton, FL: CRC Press; 1991. p. 293–305.
  • Cleeland C. The brief pain inventory user guide. Houston, TX: University of Texas M.D. Anderson Cancer Center; 2009.
  • Engel CC, von Korff M, Katon WJ. Back pain in primary care: predictors of high health-care costs. Pain. 1996;65(2–3):197–204.
  • Gore M, Sadosky A, Stacey BR, et al. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine. 2012;37(11):E668–E677.
  • Mehra M, Hill K, Nicholl D, et al. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. J Med Econ. 2012;15(2):245–252.
  • Romanelli RJ, Shah SN, Ikeda L, et al. Patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system. Am J Manag Care. 2017;23(2):e50–e56.
  • Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–2445.
  • Coyne KS, Currie BM, Donevan S, et al. Psychometric validation of the electronic chronic pain questions (eCPQ) in a primary care setting. Curr Med Res Opin. 2017;33(1):137–148.
  • Glajchen M. Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Pract. 2001;14(3):211–218.
  • Redmond K. Organizational barriers in opioid use. Support Care Cancer. 1997;5(6):451–456.
  • Yanni LM, Weaver MF, Johnson BA, et al. Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag. 2008;4(4):201–211.
  • Roth RS, Geisser ME, Williams DA. Interventional pain medicine: retreat from the biopsychosocial model of pain. Transl Behav Med. 2012;2(1):106–116.
  • Cheatle MD, Klocek JW, McLellan AT. Managing pain in high-risk patients within a patient-centered medical home. Transl Behav Med. 2012;2(1):47–56.
  • Food and Drug Administration. Public meeting on patient-focused drug development for chronic pain 2018. [cited 2018 September 18]. Available from: https://www.fda.gov/downloads/Drugs/NewsEvents/UCM612498.pdf
  • et al. Hays RD, Sherbourne CD, Spritzer KL, editors. A microcomputer program (sf36. exe) that generates SAS Code for scoring the SF-36 Health Survey. 22nd Annual SAS Users Group International Conference.; 1996.